Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Beetham Thomas W. Insider Profile
4 Followers
Beetham Thomas W., EVP & CLO at Kiniksa Pharmaceuticals, holds 0.00 shares in Kiniksa Pharmaceuticals (Ticker: KNSA).
Beetham Thomas W. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Beetham Thomas W. does not currently own shares as a corporate insider.
A breakdown of Beetham Thomas W.'s holdings
Insider Roles
EVP & CLO
Roles that Beetham Thomas W. holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Beetham Thomas W.
Beetham Thomas W.'s Trading History
List of latest transactions for each holding click on a transaction to see Beetham Thomas W.'s performance on stock
You May Also Like
Beetham Thomas W. insider profile FAQ
What is the percentage of profitable transactions made by Beetham Thomas W.?
The percentage of profitable transactions made by Beetham Thomas W. is ―.
What is the average return per transaction made by Beetham Thomas W.?
The average return per transaction made by Beetham Thomas W. is ―.
What stocks does Beetham Thomas W. hold?
Beetham Thomas W. holds: KNSA stocks.
What was Beetham Thomas W.’s latest transaction?
Beetham Thomas W. latest transaction was an Uninformative Sell of $750.68K.
What was Beetham Thomas W.'s most profitable transaction?
Beetham Thomas W.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Beetham Thomas W.'s role in Kiniksa Pharmaceuticals?
Beetham Thomas W.'s role in Kiniksa Pharmaceuticals is EVP & CLO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.